Plant responsible for contamination has been closed for two months; the FDA has not yet decided whether it can reopen
FRIDAY, June 11, 2021 (HealthDay News) — About 60 million doses of the Johnson & Johnson COVID-19 vaccine must be discarded due to possible contamination, the U.S. Food and Drug Administration has decided.
It will allow about 10 million doses to be distributed in the United States or shipped to other countries, but with a warning, according to people familiar with the situation, The New York Times reported.
More than 100 million doses of Johnson & Johnson and at least 70 million doses of AstraZeneca made at Emergent BioSolutions in Baltimore were put on hold in March after workers contaminated a batch of the Johnson & Johnson vaccine with a key ingredient used to produce the AstraZeneca vaccine.
The Emergent factory has been closed for two months and the FDA has not yet decided whether it can reopen, those with knowledge of the situation told The Times.
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes